Clinical Trial Update: Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates low-dose radiation as bridging therapy for relapsed or refractory B-cell non-Hodgkin lymphomas, including DLBCL and related indolen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• High-grade B-cell Lymphoma
• Indolent B-cell Non-hodgkin Lymphoma
• Mediastinal Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Nebraska | Conditions: DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING